0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Ahnak in the prefrontal cortex mediates behavioral correlates of stress resilience and rapid antidepressant action in mice

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The prefrontal cortex (PFC) is a key neural node mediating behavioral responses to stress and the actions of ketamine, a fast-acting antidepressant. The molecular mechanisms underlying these processes, however, are not fully understood. Our recent study revealed a pivotal role of hippocampal Ahnak as a regulator of cellular and behavioral adaptations to chronic stress. However, despite its significant expression in the PFC, the contribution of cortical Ahnak to behavioral responses to stress and antidepressants remains unknown. Here, using a mouse model for chronic social stress, we find that Ahnak expression in the PFC is significantly increased in stress-resilient mice and positively correlated with social interaction after stress exposure. Conditional deletion of Ahnak in the PFC or forebrain glutamatergic neurons facilitates stress susceptibility, suggesting that Ahnak is required for behavioral resilience. Further supporting this notion, Ahnak expression in the PFC is increased after the administration of ketamine or its metabolite ( 2R, 6R)-hydroxynorketamine (HNK). Moreover, Ahnak deletion in forebrain glutamatergic neurons blocks the restorative behavioral effects of ketamine or HNK in stress-susceptible mice. This forebrain excitatory neuron-specific Ahnak deletion reduces the frequency of mini excitatory postsynaptic currents in layer II/III pyramidal neurons, suggesting that Ahnak may induce its behavioral effects via modulation of glutamatergic transmission in the PFC. Altogether, these data suggest that Ahnak in glutamatergic PFC neurons may be critical for behavioral resilience and antidepressant actions of ketamine or HNK in chronic social stress-exposed mice.

          Related collections

          Most cited references65

          • Record: found
          • Abstract: found
          • Article: found

          Biological Insights From 108 Schizophrenia-Associated Genetic Loci

          Summary Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of alleles, including common alleles of small effect that might be detected by genome-wide association studies. Here, we report a multi-stage schizophrenia genome-wide association study of up to 36,989 cases and 113,075 controls. We identify 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance, 83 of which have not been previously reported. Associations were enriched among genes expressed in brain providing biological plausibility for the findings. Many findings have the potential to provide entirely novel insights into aetiology, but associations at DRD2 and multiple genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that play important roles in immunity, providing support for the hypothesized link between the immune system and schizophrenia.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions

            Major depression is a debilitating psychiatric illness that is typically associated with low mood and anhedonia. Depression has a heritable component that has remained difficult to elucidate with current sample sizes due to the polygenic nature of the disorder. To maximize sample size, we meta-analyzed data on 807,553 individuals (246,363 cases and 561,190 controls) from the three largest genome-wide association studies of depression. We identified 102 independent variants, 269 genes, and 15 genesets associated with depression, including both genes and gene pathways associated with synaptic structure and neurotransmission. An enrichment analysis provided further evidence of the importance of prefrontal brain regions. In an independent replication sample of 1,306,354 individuals (414,055 cases and 892,299 controls), 87 of the 102 associated variants were significant after multiple testing correction. These findings advance our understanding of the complex genetic architecture of depression and provide several future avenues for understanding etiology and developing new treatment approaches.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress.

              Mice experiencing repeated aggression develop a long-lasting aversion to social contact, which can be normalized by chronic, but not acute, administration of antidepressant. Using viral-mediated, mesolimbic dopamine pathway-specific knockdown of brain-derived neurotrophic factor (BDNF), we showed that BDNF is required for the development of this experience-dependent social aversion. Gene profiling in the nucleus accumbens indicates that local knockdown of BDNF obliterates most of the effects of repeated aggression on gene expression within this circuit, with similar effects being produced by chronic treatment with antidepressant. These results establish an essential role for BDNF in mediating long-term neural and behavioral plasticity in response to aversive social experiences.
                Bookmark

                Author and article information

                Contributors
                URI : https://loop.frontiersin.org/people/1785592/overviewRole: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/1761222/overviewRole: Role: Role:
                Role: Role: Role:
                URI : https://loop.frontiersin.org/people/1761187/overviewRole: Role:
                URI : https://loop.frontiersin.org/people/2631391/overviewRole: Role:
                Role: Role:
                Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2249691/overviewRole: Role:
                URI : https://loop.frontiersin.org/people/1223713/overviewRole: Role: Role: Role: Role: Role: Role:
                Journal
                Front Mol Neurosci
                Front Mol Neurosci
                Front. Mol. Neurosci.
                Frontiers in Molecular Neuroscience
                Frontiers Media S.A.
                1662-5099
                17 May 2024
                2024
                : 17
                : 1350716
                Affiliations
                [1] 1Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University , New York, NY, United States
                [2] 2Program in Neuroscience, Harvard Medical School , Boston, MA, United States
                [3] 3Department of Neurosurgery, Robert Wood Johnson Medical School, Rutgers University , Piscataway, NJ, United States
                [4] 4Weill Cornell Medicine Helen & Robert Appel Alzheimer’s Disease Research Institute , New York, NY, United States
                [5] 5Brain Health Institute, Rutgers University , Piscataway, NJ, United States
                Author notes

                Edited by: Qiang Gu, National Center for Toxicological Research (FDA), United States

                Reviewed by: Hee-Dae Kim, University of Arizona, United States

                Artemis Varidaki, Åbo Akademi University, Finland

                *Correspondence: Yong Kim, yk539@ 123456rwjms.rutgers.edu
                Article
                10.3389/fnmol.2024.1350716
                11140847
                8bf6ba5c-4165-406a-a17b-ed8eca2ca34a
                Copyright © 2024 Bhatti, Jin, Cheng, McCabe, Lee, Berdasco, Jeong, Sinha and Kim.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 05 December 2023
                : 12 April 2024
                Page count
                Figures: 7, Tables: 0, Equations: 0, References: 65, Pages: 13, Words: 9639
                Funding
                The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by R01MH121763 (to YK), the Black Family foundation, and the Fisher Center for Alzheimer’s Research Foundation.
                Categories
                Molecular Neuroscience
                Original Research
                Custom metadata
                Brain Disease Mechanisms

                Neurosciences
                chronic stress,susceptibility,resilience,prefrontal cortex,ahnak,ketamine,s100a10,anxa2
                Neurosciences
                chronic stress, susceptibility, resilience, prefrontal cortex, ahnak, ketamine, s100a10, anxa2

                Comments

                Comment on this article